The share price of Nufarm Limited (ASX: NUF) has tumbled over 6% since February 2 and is hovering close to a one-and-a-half year low. But the stock could be in for bounce in the short-term if Morgan Stanley’s prediction is on the money.
The broker believes there is a 70% to 80% chance the share price will outperform the broader market over the next two months as investors come to realise the stock has been oversold.
Nufarm’s share price has fallen by more than 10% over the past 12 months when the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) has added over 1%.
There’s no better time for Nufarm to play catch-up. It doesn’t report results till next month so there’s little risk of disappointing investors (assuming it doesn’t issue a profit warning, which is unlikely).
If anything, Morgan Stanley thinks it could unveil a pleasant surprise with its first half earnings announcement that is expected on March 21 in regards to its acquisition of the “Century Portfolio” of crop protection products that it is buying from Adama Agriculture Solutions and Syngenta Crop Protection AG for US$490 million.
“We note that the Century Group deal is progressing through the regulatory approval process with a decision expected in early March,” said Morgan Stanley, who has an “overweight” recommendation on Nufarm with a price target of $11.20.
“We think that the deal is likely to proceed and believe completion of the transaction and NUF’s 1H18 result will be positively received.”
Shareholders will certainly hope so as the clouded outlook for soft commodities and rising input costs has dragged on sentiment towards the stock. At least the stock looks to be stabilising around the $7.85 level.
But Morgan Stanley isn’t the only one who thinks that Nufarm’s depressed valuation is too attractive to ignore. Credit Suisse had also recently upgraded the stock to “outperform” on valuation grounds.
While Nufarm is facing some headwinds, at least its underperformance is driven more so by cyclical factors rather than structural – we are looking at you Myer Holdings Ltd (ASX: MYR)!
Nufarm is looking like an attractive option to me although this isn’t the only stock that appears well placed to outperform. The experts at the Motley Fool are particularly bullish on one niche sector of our market.
Like to find out more? Click on the link below to get your free report on this sector and to find out what stocks are best placed to ride this investment wave in 2018.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
- Is the Harvey Norman (ASX:HVN) share price next to do a capital return cashback? – February 24, 2021 12:12pm
- Monash IVF (ASX:MVF) share price jumps on profit growth and dividend restart – February 24, 2021 11:30am
- Facebook strikes first deal with Seven West (ASX:SWM) as media bargaining code looms large – February 24, 2021 9:27am